文献速递乳腺乳腺X线US

对比增强数字乳腺X线摄影在致密型乳腺女性乳腺癌检测中的诊断准确性:与断层合成、合成2D乳腺X线摄影及断层合成联合超声的比较

Diagnostic accuracy of contrast-enhanced digital mammography in breast cancer detection in comparison to tomosynthesis, synthetic 2D mammography and tomosynthesis combined with ultrasound in women with dense breast.
PubMed 文献 · Br J Radiol · 2020-12-02

前瞻性研究纳入130例致密型乳腺女性的166个病灶,以病理为金标准比较CEDM与s2D MG、DBT及DBT+超声的诊断效能。CEDM敏感度96.5%,显著高于s2D MG(75.6%)、DBT(82.8%)和DBT+超声(88.5%);CEDM特异度81%,显著高于s2D MG(63.3%),与DBT(84.4%)及DBT+超声(79.7%)无显著差异。CEDM的AUC为0.896。

要点

  • 致密型乳腺中CEDM敏感度96.5%,显著高于s2D MG、DBT及DBT+超声。
  • CEDM特异度81%,显著高于s2D MG 63.3%,与DBT及DBT+超声无显著差异。
  • CEDM的AUC为0.896,高于DBT+超声0.841、DBT 0.769和s2D MG 0.729。

核心结论

  • CEDM是致密型乳腺中检测乳腺癌的准确诊断技术,其乳腺癌检出数量显著高于s2D MG、单独DBT及DBT联合超声。

研究设计与样本

  • 前瞻性研究,纳入2019年4月至2020年6月连续就诊于症状性乳腺门诊的女性,最终分析130例患者共166个病灶,平均年龄45±12岁(范围24-72岁)。
  • 纳入标准为s2D MG显示ACR C型或D型致密型乳腺,在核心穿刺活检或手术切除前接受高分辨率乳腺超声及CEDM检查。
  • s2D MG由DBT数据后处理重建获得;以组织病理学为金标准;由两名经验丰富的乳腺放射科医生盲法阅片。

诊断标准与关键数值

  • CEDM敏感度96.5%,显著高于s2D MG 75.6%(p<0.0001)、单独DBT 82.8%(p<0.0001)及DBT+超声88.5%(p=0.0057)。
  • CEDM特异度81%,显著高于s2D MG 63.3%(p=0.0002),与单独DBT 84.4%(p=0.3586)及DBT+超声79.7%(p=0.4135)无显著差异。
  • ROC曲线分析AUC:CEDM 0.896,DBT+超声0.841,单独DBT 0.769,s2D MG 0.729。

临床应用与阅片要点

  • 在致密型乳腺女性中,CEDM对乳腺癌检测的敏感度显著高于s2D MG、单独DBT及DBT联合超声。
  • CEDM特异度显著高于s2D MG,但与单独DBT及DBT联合超声无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the diagnostic efficacy of contrast-enhanced digital mammography (CEDM) in breast cancer detection in comparison to synthetic two-dimensional mammography (s2D MG), digital breast tomosynthesis (DBT) alone and DBT supplemented with ultrasound examination in females with dense breast with histopathology as the gold-standard.

METHODS: It was a prospective study, where consecutive females presenting to symptomatic breast clinic between April 2019 and June 2020 were evaluated with DBT. Females who were found to have heterogeneously dense (ACR type C) or extremely dense (ACR type D) breast composition detected on s2D MG were further evaluated with high-resolution breast ultrasound and thereafter with CEDM, but before the core biopsy or surgical excision, were included in the study. s2D MG was derived from post-processing reconstruction of DBT data set. Females with pregnancy, renal insufficiency or prior allergic reaction to iodinated contrast agent were excluded from the study. Image interpretation was done by two experienced breast radiologists and both were blinded to histological diagnosis.

RESULTS: This study included 166 breast lesions in130 patients with mean age of 45 ± 12 years (age range 24-72 years). There were 87 (52.4%) malignant and 79 (47.6%) benign lesions. The sensitivity of CEDM was 96.5%, significantly higher than synthetic 2D MG (75.6%, p < 0.0001), DBT alone (82.8%, p < 0.0001) and DBT + ultrasound (88.5%, p = 0.0057); specificity of CEDM was 81%, significantly higher than s2D MG (63.3%, p = 0.0002) and comparable to DBT alone (84.4%, p = 0.3586) and DBT + ultrasound (79.7%, p = 0.4135). In receiver operating characteristic curve analysis, the area under the curve was of 0.896 for CEDM, 0.841 for DBT + ultrasound, 0.769 for DBT alone and 0.729 for s2D MG.

CONCLUSION: CEDM is an accurate diagnostic technique for cancer detection in dense breast. CEDM allowed a significantly higher number of breast cancer detection than the s2D MG, DBT alone and DBT supplemented with ultrasonography in females with dense breast.

ADVANCES IN KNOWLEDGE: CEDM is a promising novel technology with higher sensitivity and negative predictive value for breast cancer detection in females with dense breast in comparison to DBT alone or DBT supplemented with ultrasound.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Sudhir R, Sannapareddy K, Potlapalli A, et al. Diagnostic accuracy of contrast-enhanced digital mammography in breast cancer detection in comparison to tomosynthesis, synthetic 2D mammography and tomosynthesis combined with ultrasound in women with dense breast. Br J Radiol. 2020. PMID: 33242249. doi:10.1259/bjr.20201046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。